{
    "componentChunkName": "component---src-templates-post-js",
    "path": "/post/local-startup-1",
    "result": {"data":{"strapiPost":{"strapiId":6018,"title":"Local Startup Tackles Neonatal Opioid Withdrawal Syndrome","topic":"Health","slug":"local-startup-1","coverImage":{"publicURL":"/static/2dc30e439fba3e88c8967b3f5e34c2ec/f7bdb4690ebabe7d777f20a325f5982c.jpg"},"photoCredit":"Arkansas Capital ","date":"2023-05-16","content":"<p><a href=\"https://armoneyandpolitics.com/ua-startup-focuses-on-forgotten-victims-of-opioid-addiction/\" rel=\"noopener noreferrer\" target=\"_blank\">Pediatrica Therapeutics</a>, a pharmaceutical startup led by University of Arkansas graduate students, aims to serve the youngest victims of the opioid epidemic: unborn and newborn babies.</p><ul><li><strong>Born addicted</strong>: When a pregnant woman chronically uses opioids, <a href=\"https://armoneyandpolitics.com/ua-startup-focuses-on-forgotten-victims-of-opioid-addiction/\" rel=\"noopener noreferrer\" target=\"_blank\">neonatal opioid withdrawal syndrome</a> (NOWS) can occur, causing the baby to experience symptoms of opioid withdrawal: tremors, convulsions, vomiting, and the potential for life-long neurobehavioral problems.</li><li><strong>Making progress</strong>: Last month, Pediatrica took first place and received a $20,000 cash prize at the <a href=\"https://arcapital.com/governors-cup/\" rel=\"noopener noreferrer\" target=\"_blank\">2023 Arkansas Governor's Cup Collegiate Business Plan Competition</a> for its novel drug, developed by modifying the pharmacology of buprenorphine to serve as a fetal protectant against NOWS.</li></ul><p>Read more about Pediatrica's work <a href=\"https://armoneyandpolitics.com/ua-startup-focuses-on-forgotten-victims-of-opioid-addiction/\" rel=\"noopener noreferrer\" target=\"_blank\">HERE</a>.</p>"}},"pageContext":{"slug":"local-startup-1"}},
    "staticQueryHashes": ["161018792","3055651617","557794130"]}